Both Amiodarone and Carbamazepine offer similar effectiveness, with differences in speed and duration of relief.

Carbamazepine is gentler on the liver and kidneys, making it a safer long-term option for some patients.

Both drugs are low-risk for addiction when used properly, with minimal potential for misuse.

Both drugs are easy to use, with clear dosing schedules to ensure treatment adherence.

Amiodarone has fewer contraindications, making it suitable for patients with multiple health conditions.

Both drugs are good options depending on the patient’s needs, with Amiodarone better for quick relief and Carbamazepine for long-term management.